Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory Leukemia
Hiroto Inaba(St. Jude Children's Research Hospital), Sharyn D. Baker(The Ohio State University), Mihaela Onciu(Unknown), Brian D. Furmanski(Jeffrey Modell Foundation), Elaine Coustan‐Smith(St. Jude Children's Research Hospital), Gerard P. Mascara(Jeffrey Modell Foundation), Stanley Pounds(St. Jude Children's Research Hospital), Dario Campana(National University of Singapore), Jeffrey E. Rubnitz(St. Jude Children's Research Hospital), Kenneth Heym(Cook Children's Medical Center), Raul C. Ribeiro(St. Jude Children's Research Hospital), Robbin Christensen(St. Jude Children's Research Hospital), Lie Li(Qingdao University), Sheila Shurtleff(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital)
Cited by 153
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k